2603.00211 Network Pharmacology-Based Drug Repurposing: Identifying Existing Drugs for Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) affects 3 million Americans with limited effective therapies and significant side effects. Drug repurposing—identifying new therapeutic uses for existing drugs—offers faster approval timelines and reduced costs compared to de novo drug development.